Navigation Links
Cephalon Fourth Quarter & Full Year 2009 Earnings Conference Call Thursday, February 11, 2010 at 5:00 p.m. EST
Date:1/8/2010

FRAZER, Pa., Jan. 8 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) has scheduled its regular quarterly earnings conference call covering fourth quarter and full year 2009 results for 5:00 p.m. EST on Thursday, February 11, 2010.

February 11, 2010 Schedule


    4:10 p.m. EST  Q4 & FY 2009 results will be distributed by PRNewswire
    4:50 p.m. EST  To participate in the conference call, dial 913-312-0705
                   and refer to Conference Code Number 2954672
    5:00 p.m. EST  Conference call begins promptly.

Simultaneous Webcast

Investors can listen to the call live by logging on to the company's website at www.cephalon.com and clicking on "Investor Information," then "Webcast." Please click on the link and follow the prompts for registration and access.

If you are unable to listen to the live broadcast, an audio or webcast replay of the call will be available approximately two hours after the event until Midnight EST, February 25, 2010. To listen to the audio replay, dial 719-457-0820 and use the Conference Code Number 2954672.

Additional information presented on the conference call may be made available on the Investor Information page of the company's website.


    Contact: Robert S. (Chip) Merritt
    610-738-6376
    cmerritt@cephalon.com

SOURCE Cephalon, Inc.

RELATED LINKS
http://www.cephalon.com

'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
2. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
3. Cephalon Appoints Valli F. Baldassano as Executive Vice President and Chief Compliance Officer
4. Cephalon to Present at the 26th Annual JP Morgan Healthcare Conference
5. inVentiv Selling Solutions Selected to Provide Sales Team for Cephalon Inc.
6. Cephalon Appoints Gerald J. Pappert as General Counsel
7. Cephalon Reports Strong First Quarter Earnings
8. Cephalon Conference Call Invitation
9. Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA
10. Biopharmaceutical Company, Cephalon, To Pay $425 Million & Enter Plea to Resolve Allegations of Off-Label Marketing
11. Ohio Sales Reps Information Launched Massive Government Investigation of Cephalon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... MI (PRWEB) , ... March 24, 2017 , ... ... assistance, financial planning, and related services to families and business owners across eastern ... aimed at feeding regional families struggling with financial difficulties. , The Oxford/Orion FISH ...
(Date:3/24/2017)... ... 24, 2017 , ... Northridge dentists, Dr. Michel ... sleep apnea and TMJ at their office. TMJ, or temporomandibular joint disorder, has ... type, is increasingly being treated at dental offices with newly developed procedures and ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... http://www.hygieacare.com ) announced their partnership to prep patients for colonoscopy at the HyGIeaCare® ... Centers in 87th Ave., Miami, FL. , The HyGIeaCare® Prep, cleared ...
(Date:3/24/2017)... ... March 24, 2017 , ... “End Time GPS”: a ... will interrelate. “End Time GPS” is the creation of published author, Wesley Gerboth, ... working on military munitions and space-vehicle projects. Now, at age ninety-one, he shares the ...
(Date:3/23/2017)... & Seattle, WA (PRWEB) , ... March 23, 2017 , ... ... health emergency and now estimates that there could be four million Zika-related cases in ... epidemics to date with numbers of US cases reported per year skyrocketing to an ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... NEW YORK and GENEVA ... Agreement announced on World Tuberculosis Day revitalizes efforts to ...   On World Tuberculosis Day, TB Alliance ... agreement for the clinical development of sutezolid, an antibiotic ... The sublicense pertains to the development of sutezolid in ...
(Date:3/23/2017)... The key factors driving the growth ... accelerating economic growth and increasing healthcare expenditure. Some of the ... expectancy of ESRD patients, rising demand for home PD treatment ... of the market is hindered by high treatment costs and ... ...
(Date:3/23/2017)... INDIANAPOLIS , March 23, 2017  Eli Lilly ... William Sansum Diabetes Center have established a research collaboration ... diabetes through enhanced research, education and care. ... bears a disproportionate weight on Latino families in ... Kerr , M.D., FRCPE, director of Innovation and Research ...
Breaking Medicine Technology: